These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1719714

  • 1. Studies on linear epitopes of Semliki Forest virus in protection studies against lethal challenge virus infection.
    Truyen U, Kaaden OR.
    Zentralbl Veterinarmed B; 1991 Aug; 38(6):463-7. PubMed ID: 1719714
    [Abstract] [Full Text] [Related]

  • 2. Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine.
    Snijders A, Benaissa-Trouw BJ, Oosterlaken TA, Puijk WC, Posthumus WP, Meloen RH, Boere WA, Oosting JD, Kraaijeveld CA, Snippe H.
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():557-65. PubMed ID: 1706409
    [Abstract] [Full Text] [Related]

  • 3. Delineation of protective epitopes on the E2-envelope glycoprotein of Semliki Forest virus.
    Grosfeld H, Velan B, Leitner M, Lustig S, Lachi BE, Cohen S, Shafferman A.
    Vaccine; 1991 Jun; 9(6):451-6. PubMed ID: 1716035
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
    Boere WA, Kraaijeveld CA, Snippe H.
    Antiviral Res; 1985 Jun; Suppl 1():149-53. PubMed ID: 2417548
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A delayed-type hypersensitivity-inducing T-cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production.
    Snijders A, Benaissa-Trouw BJ, Visser-Vernooy HJ, Fernandez I, Snippe H, Kraaijeveld CA.
    Immunology; 1992 Nov; 77(3):322-9. PubMed ID: 1282493
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA, Benaissa-Trouw BJ, Harmsen T, Erich T, Kraaijeveld CA, Snippe H.
    Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Monoclonal antibodies to the E1 and E2 glycoproteins of Sindbis virus: definition of epitopes and efficiency of protection from fatal encephalitis.
    Mendoza QP, Stanley J, Griffin DE.
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3015-22. PubMed ID: 2462014
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
    Balcarova J, Helenius A, Simons K.
    J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA, Benaissa-Trouw BJ, Harmsen T, Erich T, Kraaijeveld CA, Snippe H.
    J Virol; 1985 May; 54(2):546-51. PubMed ID: 2985817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.